Ra Medical Systems (RMED) Misses Q1 EPS by 78c, Revenues Beat

Ra Medical Systems (NYSE: RMED) reported Q1 EPS of ($1.16), $0.78 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.23 million.

“I’m pleased to report that in the first quarter we completed the validation of our upgraded manufacturing process to accommodate catheter production at scale and commenced our new commercial strategy,” said Dean Irwin, CEO of Ra Medical. “We also have shifted our commercial focus toward developing long-term customer relationships. Among various actions underway, we are reevaluating the profiles and locations of our current sales personnel, upgrading our sales organization with the hiring of new, highly qualified field sales representatives and providing our reps with more comprehensive training in the use of DABRA.”

For earnings history and earnings-related data on Ra Medical Systems (RMED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c